Skip to content
Search

Latest Stories

Nardil 15mg tablets likely to remain out of stock this year

Nardil (Phenelzine sulfate)15mg tablets are expected to continue to face supply disruptions this year.

Kyowa Kirin, the sole manufacturer of Nardil tablets has said no exact date was set as to when the product would be back in stock, however the availability issues were expected to last until 2021.


Despite supply issues amid delays, the manufacturer has confirmed that the tablets have not been discontinued.

The company has already informed the Department of Health and Social Care that due to manufacturing challenges, Nardil has been out of stock since Summer 2019.

Supplies of Phenelzine 15mg tablets may be available to order from the following specialist importers on an ‘unlicensed’ basis.

ImporterContact details 
Alium MedicalTel: 020 8238 6770

Email: enquiries@aliummedical.com

Chemys LimitedTel: 02085008497

Email: orders@chemys.co.uk

Clinigen Group PLCTel: 01932 824100

Email: ukcustomerservice@clinigengroup.com

Durbin PLCTel: 0208 869 6555

Email: Imports@durbin.co.uk

Ethigen LtdTel: 0800 019 7100

Email: specials@ethigen.co.uk

Mawdsley-Brooks & CoTel: 01302 553000

Email: customerservices@mawdsleys.co.uk

Target Healthcare UK LimitedTel: 08456 180036

Email: specials@target-healthcare.co.uk

Thistle Pharma LimitedTel: 0800 169 9765

Email: contactus@thistlepharma.com

WEP ClinicalTel: 0208 004 8185

Email: info@wepclinical.com

(The list of suppliers above is not exhaustive. Credit: PSNC)

Pharmacists have been advised to note that delivery lead-times may vary between companies.

An update from the NHS Specialist Pharmacy Service (SPS) on the shortage of Nardil states: “If there is potential for a patient maintained on Phenelzine 15mg tablets to run out of supply during this shortage, they should be urgently referred back to a mental health specialist for advice on ongoing clinical management.”

According to PSNC, where prescribing of an unlicensed import is considered appropriate by the prescriber, a prescription must be issued with the wording ‘Special Order’ next to the prescribed product to ensure that a pharmacy can dispense and be correctly reimbursed for a non-Part VIIIB special.

Any EPS or paper prescription issued must specify ‘Phenelzine 15mg tablets (Special Order)’ in order for the pharmacists to dispense and be reimbursed for supplying an unlicensed import.

If a prescription is issued for ‘Phenelzine 15mg tablets‘ without any ‘Special Order’ wording against it, a pharmacy contractor would only be reimbursed the list price of £22.50 for a pack of 100 based on the reference product Nardil.

Prescriptions for unlicensed imported products not listed in Part VIIIB of the Drug Tariff must be endorsed with the following…

  • Amount dispensed over pack size used
  • Invoice price per pack size from which the order was supplied less any discount or rebate
  • Manufacturers’/importers’ MHRA licence number
  • Batch number of the product supplied.

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less